These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30968301)

  • 21. Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus.
    Calverley DC; Hacker MR; Loda KA; Brass E; Buchanan TA; Tsao-Wei DD; Groshen S
    Br J Haematol; 2003 Apr; 121(1):139-42. PubMed ID: 12670344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet FcgammaRIIA binds and internalizes IgG-containing complexes.
    Worth RG; Chien CD; Chien P; Reilly MP; McKenzie SE; Schreiber AD
    Exp Hematol; 2006 Nov; 34(11):1490-5. PubMed ID: 17046568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of the soluble form of the FcγRIIa receptor vary with receptor polymorphisms and are elevated in rheumatoid arthritis.
    Qiao J; Dunne E; Wines B; Kenny D; McCarthy GM; Hogarth PM; Xu K; Andrews RK; Gardiner EE
    Platelets; 2020; 31(3):392-398. PubMed ID: 31378115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial on "Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy" by Marcucci et al.
    Geisler T; Gawaz M
    Thromb Haemost; 2007 Oct; 98(4):705-6. PubMed ID: 17938789
    [No Abstract]   [Full Text] [Related]  

  • 27. Variability of on-treatment platelet reactivity in patients on clopidogrel.
    Freynhofer MK; Bruno V; Brozovic I; Jarai R; Vogel B; Farhan S; Hübl W; Willheim M; Wojta J; Huber K
    Platelets; 2014; 25(5):328-36. PubMed ID: 23972004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FcγRIIa ligation induces platelet hypersensitivity to thrombotic stimuli.
    Berlacher MD; Vieth JA; Heflin BC; Gay SR; Antczak AJ; Tasma BE; Boardman HJ; Singh N; Montel AH; Kahaleh MB; Worth RG
    Am J Pathol; 2013 Jan; 182(1):244-54. PubMed ID: 23141924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The administration of a loading dose of aspirin to patients presenting with acute myocardial infarction while receiving chronic aspirin treatment reduces thromboxane A2-dependent platelet reactivity.
    Santos MT; Madrid I; Moscardo A; Latorre AM; Bonastre J; Ruano M; Valles J
    Platelets; 2014; 25(4):268-73. PubMed ID: 23909754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-related biomarkers and their response to inhibition with aspirin and p2y
    Lowenstern A; Storey RF; Neely M; Sun JL; Angiolillo DJ; Cannon CP; Himmelmann A; Huber K; James SK; Katus HA; Morais J; Siegbahn A; Steg PG; Wallentin L; Becker RC;
    J Thromb Thrombolysis; 2017 Aug; 44(2):145-153. PubMed ID: 28608165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FcγRIIA-specific DARPins as novel tools in blood cell analysis and platelet aggregation.
    Riechert V; Hein S; Visser M; Zimmermann M; Wesche J; Adams PA; Theuerkauf SA; Jamali A; Wangorsch A; Reuter A; Pasternak AO; Hartmann J; Greinacher A; Herrera-Carrillo E; Berkhout B; Cichutek K; Buchholz CJ
    J Biol Chem; 2023 Jun; 299(6):104743. PubMed ID: 37100283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab and Aflibercept Activate Platelets via FcγRIIa.
    Nomura Y; Kaneko M; Miyata K; Yatomi Y; Yanagi Y
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8075-82. PubMed ID: 26720459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins have an early antiplatelet effect in patients with acute myocardial infarction.
    Matetzky S; Fefer P; Shenkman B; Shechter M; Novikov I; Savion N; Varon D; Hod H
    Platelets; 2011; 22(2):103-10. PubMed ID: 21171935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
    Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
    Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abciximab therapy is associated with increased platelet activation and decreased heparin dosage in patients with acute myocardial infarction.
    Piorkowski M; Priess J; Weikert U; Jaster M; Schwimmbeck PL; Schultheiss HP; Rauch U
    Thromb Haemost; 2005 Aug; 94(2):422-6. PubMed ID: 16113834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction.
    Eicher JD; Wakabayashi Y; Vitseva O; Esa N; Yang Y; Zhu J; Freedman JE; McManus DD; Johnson AD
    Platelets; 2016; 27(3):230-9. PubMed ID: 26367242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
    Farrell TP; Hayes KB; Sobel BE; Schneider DJ
    Am J Cardiol; 1999 Mar; 83(5):770-4. PubMed ID: 10080435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.